Due to the continued unpredictability of timing related to the closing of new contracts, the Company has not provided more specific guidance related to the timing of bookings.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/21/2022 | $3.00 | Buy | Lake Street |
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior loan covenants Atlanta, GA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM) ("Streamline" or "the Company"), a leading provider of solutions that enable healthc
Shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results. Streamline Health reported quarterly losses of 5 cents per share which missed the analyst consensus estimate of 4 cents per share. The company reported quarterly sales of $4.33 million which beat the analyst consensus estimate of $4.31 million, according to data from Benzinga Pro. Streamline Health Solutions shares dipped 23.3% to $0.4902 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers DDC Enterprise Limited (NYSE:DDC) surged 101% to $1.04. DDC Enterprise said it has acqu
SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13G/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
Lake Street resumed coverage of Streamline Health with a rating of Buy and set a new price target of $3.00
Net loss of ($2.8 million) during the second quarter of fiscal 2024 compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.3 million) for the second quarter of fiscal 2024 compared to a loss of ($0.9 million) for the second quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany updated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the second half of fiscal 2025 ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions
ATLANTA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended July 31, 2024 on Wednesday September 11, 2024 after the close of the financial markets. The Company will conduct a conference call on Thursday, September 12, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join
Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.7 million) during the first quarter of fiscal 2024 vs. a loss of ($1.3 million) during the first quarter of fiscal 2023$15.6 million of Booked SaaS ACV as of April 30, 2024 vs. $15.0 million of booked SaaS ACV as of January 31, 2024Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectation ATLANTA, June 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcar
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that is has signed a new contract for the use of eValuator with a 900-bed, Altera EHR-based health system serving northern Texas. This marks the fourth Texas health system to adopt eValuator, reinforcing Streamline Health's growing presence in the region. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-enhance pre-bill code auditing ensures that providers can accurately capture, bill and ultimat
ATLANTA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its relationship with a leading academic medical center in Florida to include the recently released eValuator Quality Module. Streamline expects that this module will increase the SaaS revenues from its eValuator relationship with this client by 20%. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-powered pre-bill code auditing analyzes 100% of encounters in real-time, en
ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its relationship with an existing eValuator client include the recently released eValuator Quality Module. Streamline expects that this module will increase the SaaS revenues from its eValuator relationship with this client by 25%. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-powered pre-bill code auditing analyzes 100% of encounters in real-time, ensuring that provide